Abraham Weizman
13Patents
4h-index
10Co-inventors
49Inventor score
Filing activity: Mar 25, 2004 → Jun 25, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7544681B2 | Conjugated psychotropic drugs and uses thereof | Human Necessities | 11 | Expired |
| US7619006B2 | Conjugated psychotropic drugs and uses thereof | Human Necessities | 10 | Active |
| US7598239B2 | Conjugated psychotropic drugs and uses thereof | Human Necessities | 10 | Active |
| US7939525B2 | Conjugated psychotropic drugs and uses thereof | Human Necessities | 8 | Active |
| US8207369B2 | Conjugates for treating neurodegenerative diseases and disorders | Chemistry; Metallurgy | 3 | Active |
| US8168628B2 | Conjugated psychotropic drugs and uses thereof | Human Necessities | 2 | Active |
| US8722923B2 | Conjugates for treating neurodegenerative diseases and disorders | Chemistry; Metallurgy | 1 | Active |
| US8975251B2 | Methods of improving cognitive functions | Human Necessities | 0 | Active |
| US8283381B2 | Conjugated psychotropic drugs and uses thereof | Human Necessities | 0 | Active |
| US8377990B2 | Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders | Human Necessities | 0 | Active |
| US8916610B2 | Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same | Chemistry; Metallurgy | 0 | Active |
| US8222296B2 | Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders | Human Necessities | 0 | Active |
| US8377929B2 | Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.